Among survey participants worried about the competitive nature of the job market, several had serious concerns about their employment prospects. One referred to the market as “an exhausting race for ...

Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ...

The word “longevity” can conjure images of billionaires swallowing bucketfuls of mysterious supplements and transfusing their blood every hour to live to 150. But with Bloomberg reporting that it is a ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.

PARIS, Dec 19 (Reuters) - Michael Saylor's Strategy (MSTR.O), opens new tab could soon be dropped from MSCI and potentially other major stock indexes, which analysts say could cost the ...

ImmunityBio, Inc. receives conditional EMA approval for Anktiva in NMIBC, following FDA and UK authorizations. IBRX faces formidable competition from JNJ’s Inlexzo, which demonstrates superior ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of ...

An HR advisor with a background in recruitment and HRIS functions, with a passion for video games and writing. Oliver grew up playing Call of Duty with his siblings and has garnered 1000s of hours ...

Structure’s aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech’s stock up nearly 103% as markets closed on Monday. Structure Therapeutics’ investigational oral GLP-1 ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...